retatrutide triple agonist gip glp-1 glucagon Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Retatrutide is a triple-agonist drug
Pay in 4 interest-free payments of $6.57 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16




/assets/images/provider/photos/2737759.jpeg)









/assets/images/provider/photos/2764906.jpg)










